search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MATERIALS | MEDICAL TUBING


Right: Evonik has devised a way to create multi-layer medical catheters, which are commonly used in


angioplasty


promising alternative to PVC for intravenous (IV) tubing applications – thanks to increased concerns about plasticiser interactions with active pharma- ceutical ingredients and a growing focus on recyclability. Kristof Verschueren, senior marketing man-


ager at Kraton, said that HSBC has a specific gravity of around 0.9, is plasticiser-free, improves drug compatibility and reduces the risk of contamination. Additionally, it has a lower moisture vapour


transmission rate (MVTR) than PVC. Process stability is another key advantage, he


said. PVC begins to degrade at 130°C, while HSBC sees minimal degradation up to 250°C and produces minimal hazardous chemicals during thermal processing or combustion. In addition, its compatibility with polyolefins makes for easier recyclability, he said. Key features of HSBC medical tubing – such as


phthalate- and plasticiser-free formulations, good mechanical and optical properties and high flexibility – create benefits such as improved patient safety, compliance with sterilisation needs and kink resistance.


Multi-layer catheters Evonik has devised a method to create multi-layer medical catheters in a single manufacturing step. A major difficulty in creating these devices is to


join different materials together, which often involves the use of tie-layers and multiple produc- tion steps.


“Multi-layer catheters are common in angioplas- ty and require a combination of dissimilar poly-


saldi@jwell.cn


IMAGE: SHUTTERSTOCK


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50